| scholarly article | Q13442814 |
| review article | Q7318358 |
| meta-analysis | Q815382 |
| P2093 | author name string | David C Mohr | |
| Daniel Pelletier | |||
| Darcy Cox | |||
| Laura Julian | |||
| Stacey L Hart | |||
| P2860 | cites work | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
| A serial study of new MS lesions and the white matter from which they arise | Q28291585 | ||
| Multiple sclerosis | Q29616022 | ||
| Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis | Q33630098 | ||
| PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS. | Q34260415 | ||
| Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes | Q34262743 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Interferons in relapsing remitting multiple sclerosis: a systematic review | Q34531565 | ||
| Self reported stressful life events and exacerbations in multiple sclerosis: prospective study | Q34542101 | ||
| Mast cells: new targets for multiple sclerosis therapy? | Q35012299 | ||
| A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. | Q36881126 | ||
| An investigation of the psychiatric aspects of disseminated sclerosis | Q37198581 | ||
| The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation | Q40506162 | ||
| The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis | Q40546571 | ||
| Glucocorticoids and stress: permissive and suppressive actions | Q40572616 | ||
| Psychological stress and the subsequent appearance of new brain MRI lesions in MS. | Q40757694 | ||
| Reappraisal of possible etiologic factors in multiple sclerosis | Q43321612 | ||
| Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis | Q43670227 | ||
| Environmental triggers in multiple sclerosis. Fact or fallacy? | Q44402106 | ||
| Structural brain correlates of emotional disorder in multiple sclerosis | Q45143536 | ||
| Emotional stress and coping in multiple sclerosis (MS) exacerbations | Q46702513 | ||
| The role of psychological process in a somatic disorder: multiple sclerosis. 1. The emotional setting of illness onset and exacerbation | Q47755664 | ||
| Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats | Q47910786 | ||
| Neuroendocrine influences on experimental autoimmune encephalomyelitis | Q47966420 | ||
| 2002 Robert Ader New Investigator award. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity | Q48329480 | ||
| Psychological stress as risk factor for exacerbations in multiple sclerosis. | Q53735875 | ||
| Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship | Q70515628 | ||
| [Organic personality syndrome in multiple sclerosis and effect of stress on recurrent attacks] | Q72458433 | ||
| Stress and course of disease in multiple sclerosis | Q73367180 | ||
| Stressful life events and multiple sclerosis: a retrospective study | Q74137604 | ||
| The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology | Q77890182 | ||
| Stressful life events precede exacerbations of multiple sclerosis | Q78598834 | ||
| P433 | issue | 7442 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychological stress | Q3500368 |
| multiple sclerosis | Q8277 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 731 | |
| P577 | publication date | 2004-03-19 | |
| 2004-03-27 | |||
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis | |
| P478 | volume | 328 |
| Q36968527 | A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling |
| Q46875995 | A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis |
| Q48842754 | A prospective population-based study of triggers of symptomatic flares in IBD. |
| Q36117334 | A randomized trial of stress management for the prevention of new brain lesions in MS |
| Q91762888 | A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study |
| Q36206179 | A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables |
| Q92640062 | Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients |
| Q60636651 | Ambulatory Assessment in Neuropsychology |
| Q37569107 | Antecedents of Coping with the Disease in Patients with Multiple Sclerosis: A Qualitative Content Analysis |
| Q90303294 | Association Between Noninfectious Uveitis and Psychological Stress |
| Q93271339 | Behavioral Interventions in Multiple Sclerosis |
| Q42789516 | Biological outcome measurements for behavioral interventions in multiple sclerosis |
| Q92389829 | Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis |
| Q104509556 | Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis |
| Q36946327 | Brain-immune communication psychoneuroimmunology of multiple sclerosis |
| Q24563348 | Brain-skin connection: stress, inflammation and skin aging |
| Q59809046 | Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis? |
| Q34220882 | Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. |
| Q49874514 | Clinical Course of Multiple Sclerosis |
| Q39183454 | Comorbidity in multiple sclerosis: implications for patient care |
| Q36721039 | Correlates of participation in meaningful activities among people with multiple sclerosis |
| Q39229363 | Corticosteroids in the management of acute multiple sclerosis exacerbations. |
| Q40422131 | Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study |
| Q36134737 | Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation |
| Q33802341 | Effects of stress on the immune response to Theiler's virus--implications for virus-induced autoimmunity |
| Q37692820 | Environmental factors and their timing in adult-onset multiple sclerosis |
| Q38663577 | Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop |
| Q37217845 | Examining the evidence: complementary adjunctive therapies for multiple sclerosis |
| Q35876398 | FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value |
| Q48442984 | Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis |
| Q37209917 | Gender and sex hormones in multiple sclerosis pathology and therapy. |
| Q36432500 | Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system? |
| Q37442324 | Headache in multiple sclerosis: features and implications for disease management |
| Q36582315 | Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis |
| Q64991182 | Hybrid Resiliency-Stressor Conceptual Framework for Informing Decision Support Tools and Addressing Environmental Injustice and Health Inequities. |
| Q38665413 | Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study |
| Q89471144 | Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial |
| Q36789329 | Increased percentages of regulatory T cells are associated with inflammatory and neuroendocrine responses to acute psychological stress and poorer health status in older men and women |
| Q50778662 | Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study. |
| Q42282484 | Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection. |
| Q34831961 | Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis? |
| Q37669992 | Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis |
| Q47906763 | Major stressful life events in adulthood and risk of multiple sclerosis. |
| Q39070531 | Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs |
| Q83029950 | Mast cells and inflammation |
| Q38238089 | Meditation as an adjunct to the management of multiple sclerosis |
| Q37510816 | Mindfulness based interventions in multiple sclerosis--a systematic review |
| Q42667364 | Mindfulness in Motion for People with Multiple Sclerosis: A Feasibility Study |
| Q30851153 | Mindfulness-based stress reduction for people with multiple sclerosis - a feasibility randomised controlled trial |
| Q33581753 | Modifiable factors influencing relapses and disability in multiple sclerosis. |
| Q59292246 | Multiple sclerosis |
| Q36832915 | Multiple sclerosis and behavior |
| Q45328886 | Multiple sclerosis in gulf war era veterans. 2. Military deployment and risk of multiple sclerosis in the first gulf war. |
| Q35521828 | Multiple sclerosis: diagnosis and the management of acute relapses |
| Q50761855 | Negative affect predicts subsequent cognitive change in multiple sclerosis. |
| Q36203188 | Negative life events and quality of life in adults with asthma |
| Q90633328 | Neighborhood Deprivation and Risks of Autoimmune Disorders: A National Cohort Study in Sweden |
| Q33821426 | Neuroimmune interactions in a model of multiple sclerosis |
| Q28220405 | Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression |
| Q41886918 | Paradigms in multiple sclerosis: time for a change, time for a unifying concept |
| Q53128163 | Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. |
| Q34540627 | Patterns of mind-body therapies in adults with common neurological conditions |
| Q33563400 | Perceived stress in multiple sclerosis: the potential role of mindfulness in health and well-being. |
| Q38921991 | Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application. |
| Q36972200 | Psychiatric issues in multiple sclerosis |
| Q37076392 | Psychological stress is associated with relapse in type 1 autoimmune hepatitis |
| Q58803285 | Relation between personality disorders and characteristics of multiple sclerosis patients and their parents |
| Q34569849 | Relationship between stress and relapse in multiple sclerosis: Part I. Important features |
| Q34569853 | Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships. |
| Q35546124 | Restraint stress fails to render C57BL/6 mice susceptible to Theiler's virus-induced demyelination |
| Q37261196 | Restraint stress modulates virus specific adaptive immunity during acute Theiler's virus infection |
| Q93013981 | Role of the End-Point Mediators of Sympathoadrenal and Sympathoneural Stress Axes in the Pathogenesis of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis |
| Q88543531 | Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4+ T-cell subsets in multiple sclerosis patients |
| Q36862803 | Social conflict exacerbates an animal model of multiple sclerosis. |
| Q40924215 | Social disruption alters pain and cognition in an animal model of multiple sclerosis |
| Q35489039 | Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release |
| Q28241987 | Stress and health: psychological, behavioral, and biological determinants |
| Q36822089 | Stress and multiple sclerosis |
| Q37540661 | Stress and multiple sclerosis: A systematic review considering potential moderating and mediating factors and methods of assessing stress |
| Q35047517 | Stress and the risk of multiple sclerosis. |
| Q37066880 | Stress as provoking factor for the first and repeated multiple sclerosis seizures. |
| Q38150625 | Stress in multiple sclerosis: review of new developments and future directions |
| Q22241797 | Stress regulation in multiple sclerosis-current issues and concepts |
| Q37451337 | Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis |
| Q40592757 | Stressful life events and the risk of initial central nervous system demyelination. |
| Q50561185 | Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study. |
| Q34622229 | Symptom changes in multiple sclerosis following psychological interventions: a systematic review. |
| Q40616088 | The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis |
| Q37360503 | The effects of stressful life events on the course of multiple sclerosis: a review |
| Q64331504 | The use of traditional and complementary medicine among patients with multiple sclerosis in Belgium |
| Q37320173 | Three years evaluation of drug shortages from educational pharmacies in tehran |
| Q36818747 | Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy. |
| Q50775298 | Unemployment among women with multiple sclerosis: the role of coping and perceived stress and support in the workplace. |
| Q36364203 | Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression |
| Q92357948 | Unlocking stress and forecasting its consequences with digital technology |
| Q26864921 | Vascular inward rectifier K+ channels as external K+ sensors in the control of cerebral blood flow |
| Q87907439 | [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice] |
Search more.